SpaceX’s $350M profit silences skeptics; FDA faces AI drug test.
Curious Professional por Curious Professional/askcuriousprofessional@gmail.com
Notas del episodio
The European Union is fundamentally rewriting the economics of tech manufacturing, forcing giants like Apple and Samsung into a difficult pricing corner ahead of the holidays. Meanwhile, SpaceX's surprise $350 million profit proves the commercial space race is now a brutal battle of balance sheets, and regulators face uncharted territory as they evaluate the first AI-hallucinated drug.
• EU's Tech Carbon Tax: A new tariff on servers and smartphones forces manufacturers to abandon cheap coal power, threatening holiday profit margins for major tech companies.
• SpaceX's First Earnings: The aerospace giant posts a surprise $350M profit on $4.2B in revenue, driven by 5 million active Starlink subscribers.
• Eli Lilly's AI Milestone: The first fully AI-designed drug passes Phase 3 trials in under three years, setting the stage for a biotech M&A wave.
• ...
Leer más